Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2010 • 14,016 citations

The blockade of immune checkpoints in cancer immunotherapy

2012 • 12,062 citations

TH-17 cells in the circle of immunity and autoimmunity

2007 • 1,520 citations

Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab

2012 • 1,353 citations

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

2009 • 1,139 citations

Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

1996 • 1,110 citations

Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

2005 • 997 citations

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

2008 • 683 citations

Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

2007 • 673 citations

Principles and use of anti-CTLA4 antibody in human cancer immunotherapy

2006 • 437 citations

Ipilimumab: controversies in its development, utility and autoimmune adverse events

2009 • 223 citations

Anti-CTLA-4 antibody-induced Guillain–Barré syndrome in a melanoma patient

2011 • 171 citations

CTLA4 blockade increases Th17 cells in patients with metastatic melanoma

2009 • 165 citations

Releasing the Brake on the Immune System: Ipilimumab in Melanoma and Other Tumors

2010 • 148 citations

Cytotoxic T-Lymphocyte-Associated Antigen 4 Antibody-Induced Colitis and Its Management with Infliximab

2008 • 133 citations

Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma

2011 • 123 citations

Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis.

2011 • 119 citations

Ipilimumab safety profile: Summary of findings from completed trials in advanced melanoma.

2011 • 118 citations

Autoimmune Inflammatory Myopathy after Treatment with Ipilimumab

2009 • 104 citations

Intracranial and intraspinal meningeal melanocytosis.

2000 • 85 citations

Multifocal radiculoneuropathy during ipilimumab treatment of melanoma

2013 • 71 citations

Acute ascending necrotizing myelopathy caused by herpes simplex virus type 2

1987 • 69 citations

Severe meningo-radiculo-nevritis associated with ipilimumab

2012 • 67 citations

Characteristics and management of immune-related adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanoma

2012 • 64 citations

Necrotizing myelopathy associated with malignancy. A clinicopathologic study of two cases and literature review

1984 • 64 citations

Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities

2012 • 56 citations

Progressive Necrotic Myelopathy

2000 • 53 citations

Profile of ipilimumab and its role in the treatment of metastatic melanoma

2011 • 37 citations

Necrotizing Myelopathy Complicating Hodgkin's Disease

1979 • 30 citations

Cranial Neuropathy as a Presenting Sign of Recurrent Aggressive Skin Cancer

2008 • 20 citations

Necrotizing myelopathy associated with hepatocellular carcinoma.

1988 • 14 citations

[Nationwide survey of necrotizing myelopathy associated with malignancy in Japan].

1991 • 1 citations